The schizophrenia drug, made by AstraZeneca, appears to be safe in working with other depression treatments, a committee says.
Original post by By REUTERS
Posts Related to F.D.A. Panel Endorses New Use for Seroquel XR
Drug Maker’s E-Mail Released in Seroquel Lawsuit
In an e-mail message, an AstraZeneca physician was praised for doing “a great ‘smoke-and-mirrors’ job” in muting adverse data. Original post by By DUFF WILSON
F.D.A. Panel Endorses Lilly Blood Thinner
The drug, called prasugrel, could pose the first real challenge to Bristol-Myers Squibb’s near monopoly on blood-thinning drugs. Original post by By NATASHA SINGER
Depression Tests Urged for Teenagers
An influential government-appointed medical panel is urging doctors to routinely screen all American teenagers for depression. Original post by By THE ASSOCIATED PRESS
F.D.A. Panel Approves Lilly Drug for Clotting
If the regulators approve the new drug developed by Lilly, it could end the monopoly in the market enjoyed by Bristol-Myers Squibb’s blood thinner, Plavix. ...
House Panel Questions Industry on Food Safety
After more than 20 hearings over two years, powerful members of the Energy and Commerce Committee said food safety oversight reforms would pass soon. Original ...